The IN-MIDAZ study - Intranasal midazolam in aborting seizures - An epilepsy monitoring unit based randomized controlled trial for efficacy
NeurologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Epilepsy research
- Publicado em
- 20 out 2022
- Citações
- 7
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
The IN-MIDAZ study - Intranasal midazolam in aborting seizures - An epilepsy monitoring unit based randomized controlled trial for efficacy
Raja Gulfam Shaikh, Bhargavi Ramanujan, Rajesh Kumar Singh, Deepti Vibha, Santosh Mehta, Renjith Appukuttan, Manjari Tripathi
Descritores MeSH
- Drug Resistant Epilepsy
- Status Epilepticus
- Adult
- Anticonvulsants
- Child
- Humans
- Midazolam
- Seizures
- Administration, Intranasal
Veja também
Estudos relacionados
- Efficacy and Tolerability of Intranasal Midazolam Administration for Antiseizure Treatment in Adults: A Systematic Review
- Intranasal midazolam versus intravenous/rectal benzodiazepines for acute seizure control in children: A systematic review and meta-analysis
- Recommendations for the community-based management of prolonged convulsive seizures in children in Europe
- Management of the first stage of convulsive status epilepticus in adults: a systematic review of current randomised evidence